This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Salbutamol - AAH Pharmaceuticals Ltd

AAH Pharmaceuticals

Description

Short-acting selective beta2 agonist.

Oral
(Please note, inhalation route preferred over oral route in children.)
• Child 1 month–1 year: 100 mcg/kg (maximum 2 mg) 3–4 times daily
• Child 2–5 years: 1–2 mg, 3–4 times daily
• Child 6–11 years: 2 mg, 3–4 times daily
• Child 12–17 years: 2–4 mg, 3–4 times daily
• Over 18 years: 4 mg (elderly and sensitive patients initially 2 mg), 3–4 times daily, with a maximum single dose of 8 mg (but unlikely to provide much extra benefit or to be tolerated).

Moderate to severe or life-threatening acute asthma, treated by inhalation of nebulised solution. Give via a large volume spacer, and via a close-fitting face mask in children under 3 years.
• Child 1 month–4 years: 2.5 mg, repeat every 20–30 minutes or when required.
• Child 5–11 years: 2.5–5 mg, repeat every 20–30 minutes or when required.
• Over 12 years: 5 mg, repeat every 20–30 minutes or when required.

Indications

Asthma and other conditions associated with reversible airways obstruction.

Preparations Available

Tablet, Nebuliser liquid

Sizes Available

Tablets
2 mg, pack of 28 
4 mg, pack of 28 

Nebuliser liquid
2.5 mg/2.5 ml, 20 vials 
5 mg/2.5 ml, 20 vials 

More on: Bronchodilators , Short-acting selective beta2: agonists